The overall incidence of MYC-R in the series was 28% (14/50 cases): 1 HGBCL-NOS, 8 HGBCL with MYC-BLC2/BCL6 R, 4 DLBCL-NOS and 1 BL. This evidence concerns the gene MYC and Burkitt lymphoma.